2024 Sotoracib (AMG510) latest price

Sotoraxib (AMG510) is a drug that targets specific cancer mutations and has attracted attention for showing potential efficacy in treating certain types of tumors. However, in China, sotorasibu has not yet been officially launched, which prevents domestic patients from purchasing it directly. However, they still have access to the drug overseas. In overseas markets, sotorasibu can be divided into two types: original drugs and generic drugs, and the price difference is also obvious.

First of all, the original drug includes the European version and the Hong Kong version. Due to their unique production processes and technical advantages, these original drugs are relatively expensive, usually in the price range of tens of thousands or even higher. This discourages many patients as it is expensive and not everyone can afford it.

In contrast, the prices of generic drugs that have been launched overseas are more affordable. Take generic drugs in Laos as an example. Recently, the prices of generic drugs produced by Laos Lucius and Laos Big Bear have been significantly reduced. Now, patients only need to pay more than 1,000 to 2,000 yuan to purchase this drug. Compared with the original drug, this undoubtedly reduces a lot of financial pressure on patients who need treatment.

In addition, it is worth noting that the ingredients of original drugs and generic drugs are basically the same. Therefore, in terms of efficacy and safety, there is not much difference between the two. This also means that patients can consider price more when choosing, without having to worry too much about drug quality.

In general, although sotoracib is not yet available in China, patients still have the opportunity to obtain this drug through overseas channels. In overseas markets, original drugs are expensive, while generic drugs are relatively cheap, which provides more choices for patients in need of treatment. Therefore, patients can make rational choices based on their actual situation and financial ability.